Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function
- 1 August 2002
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 107 (3-4) , 135-139
- https://doi.org/10.1016/s0049-3848(02)00260-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immune Thrombocytopenic PurpuraNew England Journal of Medicine, 2002
- Autoimmune (idiopathic) thrombocytopenic purpuraThe Lancet, 1997
- A non‐thrombocytopenic bleeding disorder due to an IgG4‐kappa anti‐GPIIb/IIIa autoantibodyBritish Journal of Haematology, 1996
- Evidence for a light chain restriction of glycoprotein Ib/IX and Ilb/IIIa reactive antibodies in chronic idiopathic thrombocytopenic purpura (ITP)British Journal of Haematology, 1995
- Influences of antiplatelet autoantibodies on platelet function in immune thrombocytopenic purpuraEuropean Journal of Haematology, 1991
- Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodiesBlood, 1987
- Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpuraBlood, 1981
- Autoimmune thrombocytopenic purpuraBlood, 1980
- The Bleeding Time as a Screening Test for Evaluation of Platelet FunctionNew England Journal of Medicine, 1972
- Qualitative Platelet Abnormalities in Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1972